Literature DB >> 19127578

Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.

Christopher G Goetz1, Murat Emre, Bruno Dubois.   

Abstract

Cognitive impairment is common in Parkinson's disease (PD) and involves attentional, executive, visuospatial, and memory dysfunctions. Dementia is more frequently encountered in PD than in age-matched control populations, and whereas operational definitions of Alzheimer's disease and dementia with Lewy bodies have been developed, Parkinson's disease dementia (PD-D) has remained undefined. The Movement Disorder Society developed a task force to define and develop diagnostic guidelines for PD-D. This effort was based on existing descriptive studies with special emphasis on drawing distinction among Alzheimer's disease, dementia with Lewy bodies and PD-related cognitive impairment without dementia whenever possible. The second goal was to provide practical diagnostic procedures to diagnose PD-D. This effort emphasized available bedside tools that do not require neuropsychological expertise to administer or interpret. This work recently has been completed, and two primary articles have been published. The suggested clinical diagnostic criteria for PD-D involve four domains and are anchored in core features, associated clinical features, features that make the diagnosis uncertain, and features that are not compatible with the diagnosis of PD-D. When all four criteria are satisfactorily met, probable PD-D is designated; when the first and last criteria are met, but clinical characteristics are atypical or uncertainty factors exist, possible PD-D is designated. Whereas these definitions are operative and subject to change based on future data, they are based on widely available tests. The inclusion criteria can be applied internationally and in multicenter research on treatment interventions, clinicopathological correlations, and studies of cognitive and other nonmotor elements of PD.

Entities:  

Mesh:

Year:  2008        PMID: 19127578     DOI: 10.1002/ana.21455

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  51 in total

Review 1.  Biomarkers for cognitive impairment in Parkinson disease.

Authors:  Min Shi; Bertrand R Huber; Jing Zhang
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

2.  Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.

Authors:  Jon B Toledo; Pallavi Gopal; Kevin Raible; David J Irwin; Johannes Brettschneider; Samantha Sedor; Kayla Waits; Susana Boluda; Murray Grossman; Vivianna M Van Deerlin; Edward B Lee; Steven E Arnold; John E Duda; Howard Hurtig; Virginia M-Y Lee; Charles H Adler; Thomas G Beach; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2015-12-31       Impact factor: 17.088

3.  Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Han-Joon Kim; Beom S Jeon; Sun Ha Paek; Kyoung-Min Lee; Ji-Young Kim; Jee-Young Lee; Hee Jin Kim; Ji Young Yun; Young Eun Kim; Hui-Jun Yang; Gwanhee Ehm
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

Review 4.  Medication nonadherence in Parkinson's disease.

Authors:  Jori E Fleisher; Matthew B Stern
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

5.  Cortical gray and subcortical white matter associations in Parkinson's disease.

Authors:  Nicholas W Sterling; Guangwei Du; Mechelle M Lewis; Steven Swavely; Lan Kong; Martin Styner; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2016-09-28       Impact factor: 4.673

Review 6.  Neuropathobiology of non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-15       Impact factor: 3.575

7.  Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats.

Authors:  Sonu Singh; Akanksha Mishra; Neha Srivastava; Rakesh Shukla; Shubha Shukla
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

8.  Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study.

Authors:  S Gazzina; E Premi; R Turrone; J Acosta-Cabronero; M C Rizzetti; M S Cotelli; R Gasparotti; A Padovani; B Borroni
Journal:  J Neurol       Date:  2016-05-26       Impact factor: 4.849

9.  Validity and metric of MiniMental Parkinson and MiniMental State Examination in Parkinson's disease.

Authors:  V Isella; C Mapelli; N Morielli; D De Gaspari; C Siri; G Pezzoli; A Antonini; M Poletti; U Bonuccelli; L Picchi; A Napolitano; M Vista; A Greco; I M Appollonio
Journal:  Neurol Sci       Date:  2013-02-20       Impact factor: 3.307

10.  A new approach for the quantitative evaluation of the clock drawing test: preliminary results on subjects with Parkinson's disease.

Authors:  Maria Francesca De Pandis; Manuela Galli; Sara Vimercati; Veronica Cimolin; Maria Vittoria De Angelis; Giorgio Albertini
Journal:  Neurol Res Int       Date:  2010-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.